These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 38676365)

  • 1. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β-catenin axis.
    Shi X; Hu Z; Bai S; Zong C; Xue H; Li Y; Li F; Chen L; Xuan J; Xia Y; Wei L; Shen F; Wang K
    J Gene Med; 2024 May; 26(5):e3689. PubMed ID: 38676365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway.
    Zhang H; Dong X; Ding X; Liu G; Yang F; Song Q; Sun H; Chen G; Li S; Li Y; Wang M; Guo T; Zhang Z; Li B; Yang L
    J Transl Med; 2023 Dec; 21(1):900. PubMed ID: 38082327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1.
    Ning F; Du L; Li J; Wu T; Zhou J; Chen Z; Hu X; Zhang Y; Luan X; Xin H; Yuan C; Zhang X
    Life Sci; 2024 Jul; 348():122674. PubMed ID: 38692507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.
    Liang Z; Ge Y; Li J; Bai Y; Xiao Z; Yan R; An G; Zhang D
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):342. PubMed ID: 38980538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR/SREBP-1 pathway based on single-cell RNA sequencing.
    Huang T; Cao H; Liu C; Sun X; Dai S; Liu L; Wang Y; Guo C; Wang X; Gao Y; Tang W; Xia Y
    Cell Death Dis; 2024 Jun; 15(6):411. PubMed ID: 38866777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase interacting BCLAF1 to promote the development and drug resistance of ICC through the PERK/eIF2α pathway.
    Yuan F; Zhou H; Liu C; Wang Y; Quan J; Liu J; Li H; von Itzstein M; Yu X
    Cancer Gene Ther; 2024 Jun; 31(6):904-916. PubMed ID: 38467765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/β-catenin Signaling Pathway.
    Yang Y; Yuan Y; Xia B
    Curr Stem Cell Res Ther; 2024; 19(7):1021-1028. PubMed ID: 37861049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma.
    Sun BY; Zhang D; Gan W; Wu JF; Wang ZT; Sun GQ; Zhou J; Fan J; Yi Y; Hu B; Zhang BH; Qiu SJ
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):348. PubMed ID: 39002018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digitoxin inhibits ICC cell properties via the NF‑κB/ST6GAL1 signaling pathway.
    Zhan Y; Wang R; Huang C; Xu X; Xiao X; Wu L; Wei J; Long T; Gao C
    Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38940341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma.
    Xiong F; Wang D; Xiong W; Wang X; Huang WH; Wu GH; Liu WZ; Wang Q; Chen JS; Kuai YY; Wang B; Chen YJ
    J Exp Clin Cancer Res; 2024 May; 43(1):152. PubMed ID: 38812060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer.
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Mol Biol Rep; 2024 May; 51(1):691. PubMed ID: 38796671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathway.
    Lin M; Tu RH; Wu SZ; Zhong Q; Weng K; Wu YK; Lin GT; Wang JB; Zheng CH; Xie JW; Lin JX; Chen QY; Huang CM; Cao LL; Li P
    Cell Death Dis; 2024 Jul; 15(7):497. PubMed ID: 38997271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FATP5 Is Indispensable for the Growth of Intrahepatic Cholangiocarcinoma.
    Shihadih D; Wang X; Zushin PH; Khodakivskyi P; Park HM; Tso E; Shiblak J; Misic A; Louie SM; Ward C; Hellerstein M; Nomura DK; Goun E; Urigo F; Calvisi DF; Chen X; Stahl A
    Mol Cancer Res; 2024 Jun; 22(6):585-595. PubMed ID: 38358323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma.
    Luk IS; Bridgwater CM; Yu A; Boila LD; Yáñez-Bartolomé M; Lampano AE; Hulahan TS; Boukhali M; Kathiresan M; Macarulla T; Kenerson HL; Yamamoto N; Sokolov D; Engstrom IA; Sullivan LB; Lampe PD; Cooper JA; Yeung RS; Tian TV; Haas W; Saha SK; Kugel S
    Sci Transl Med; 2024 May; 16(747):eadj7685. PubMed ID: 38748774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating PCGF4/BMI1 Stability Is an Efficient Metastasis-Regulatory Strategy Used by Distinct Subtypes of Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma.
    Hu J; Xu H; Ma X; Bai M; Zhou Y; Miao R; Wang F; Li X; Cheng B
    Am J Pathol; 2024 Jul; 194(7):1388-1404. PubMed ID: 38670529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
    Wang Y; Zhao G; Condello S; Huang H; Cardenas H; Tanner EJ; Wei J; Ji Y; Li J; Tan Y; Davuluri RV; Peter ME; Cheng JX; Matei D
    Cancer Res; 2021 Jan; 81(2):384-399. PubMed ID: 33172933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism.
    Duan Y; Deng M; Liu B; Meng X; Liao J; Qiu Y; Wu Z; Lin J; Dong Y; Duan Y; Sun Y
    Biomaterials; 2024 Sep; 309():122609. PubMed ID: 38754290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma.
    Deng S; Lu X; Wang X; Liang B; Xu H; Yang D; Cui G; Yonemura A; Paine H; Zhou Y; Zhang Y; Simile MM; Urigo F; Evert M; Calvisi DF; Green BL; Chen X
    Cell Death Dis; 2024 Jun; 15(6):441. PubMed ID: 38909034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota regulates the ALK5/NOX1 axis by altering glutamine metabolism to inhibit ferroptosis of intrahepatic cholangiocarcinoma cells.
    Zhang Q; Zhou J; Zhai D; Jiang Q; Yang M; Zhou M
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167152. PubMed ID: 38582012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Growth Factors; 2024 May; 42(2):84-100. PubMed ID: 38889447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.